Kuros Biosciences AG (0RHR.L)
CHF 20.55
(1.23%)
CHF 20.55
(1.23%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -10.4 Million CHF | 30.4% |
| 2022 | -8.84 Million CHF | -67.08% |
| 2021 | -5.29 Million CHF | 38.31% |
| 2020 | -8.57 Million CHF | -1.41% |
| 2019 | -8.45 Million CHF | 27.96% |
| 2018 | -11.74 Million CHF | 8.68% |
| 2017 | -15.09 Million CHF | 33.43% |
| 2016 | -19.31 Million CHF | -262.5% |
| 2015 | -4.06 Million CHF | 163.46% |
| 2014 | -18.84 Million CHF | 18.28% |
| 2013 | -22.92 Million CHF | -266.42% |
| 2012 | -6.3 Million CHF | 55.51% |
| 2011 | -14.05 Million CHF | -394.9% |
| 2010 | 4.76 Million CHF | 126.73% |
| 2009 | -17.83 Million CHF | 4.93% |
| 2008 | -18.76 Million CHF | -133.39% |
| 2007 | -3.27 Million CHF | 75.02% |
| 2006 | -31.7 Million CHF | -20.31% |
| 2005 | -26.75 Million CHF | -22.96% |
| 2004 | -21.75 Million CHF | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 605 Thousand CHF | 0.0% |
| 2023 Q2 | -3.24 Million CHF | -87.14% |
| 2023 Q1 | -1.73 Million CHF | 72.48% |
| 2023 Q4 | -2.9 Million CHF | -88.04% |
| 2023 Q3 | -1.54 Million CHF | 52.34% |
| 2023 FY | - CHF | 30.4% |
| 2022 Q4 | -6.3 Million CHF | -92.57% |
| 2022 FY | - CHF | -67.08% |
| 2022 Q1 | -478 Thousand CHF | 91.99% |
| 2022 Q2 | -1.07 Million CHF | -124.48% |
| 2022 Q3 | -3.27 Million CHF | -204.94% |
| 2021 Q2 | -125 Thousand CHF | -3471.43% |
| 2021 Q1 | -3500.00 CHF | 99.92% |
| 2021 Q3 | -3.16 Million CHF | -2433.6% |
| 2021 Q4 | -5.97 Million CHF | -88.51% |
| 2021 FY | - CHF | 38.31% |
| 2020 Q3 | -2.22 Million CHF | 56.79% |
| 2020 FY | - CHF | -1.41% |
| 2020 Q4 | -4.17 Million CHF | -87.72% |
| 2020 Q1 | -2.51 Million CHF | 47.42% |
| 2020 Q2 | -5.14 Million CHF | -104.33% |
| 2019 FY | - CHF | 27.96% |
| 2019 Q2 | -4.16 Million CHF | -109.13% |
| 2019 Q3 | -2.49 Million CHF | 40.19% |
| 2019 Q1 | -1.99 Million CHF | 40.86% |
| 2019 Q4 | -4.79 Million CHF | -92.14% |
| 2018 FY | - CHF | 8.68% |
| 2018 Q3 | -3.37 Million CHF | -33.73% |
| 2018 Q2 | -2.52 Million CHF | 0.0% |
| 2018 Q4 | -3.37 Million CHF | 0.0% |
| 2018 Q1 | -2.52 Million CHF | 42.14% |
| 2017 Q2 | -3.19 Million CHF | 0.0% |
| 2017 Q4 | -4.35 Million CHF | 0.0% |
| 2017 Q1 | -3.19 Million CHF | 9.91% |
| 2017 Q3 | -4.35 Million CHF | -36.43% |
| 2017 FY | - CHF | 33.43% |
| 2016 Q2 | -6.71 Million CHF | 0.0% |
| 2016 Q3 | -3.54 Million CHF | 47.27% |
| 2016 FY | - CHF | -262.5% |
| 2016 Q1 | -6.71 Million CHF | -329.22% |
| 2016 Q4 | -3.54 Million CHF | 0.0% |
| 2015 FY | - CHF | 163.46% |
| 2015 Q4 | -1.56 Million CHF | 0.0% |
| 2015 Q3 | -1.56 Million CHF | -188.04% |
| 2015 Q2 | -543.5 Thousand CHF | 0.0% |
| 2015 Q1 | -543.5 Thousand CHF | 0.0% |
| 2014 FY | - CHF | 18.28% |
| 2013 Q3 | -5.69 Million CHF | 8.95% |
| 2013 Q4 | -7.33 Million CHF | -28.76% |
| 2013 Q2 | -6.25 Million CHF | -74.59% |
| 2013 FY | - CHF | -266.42% |
| 2013 Q1 | -3.58 Million CHF | -211.96% |
| 2012 Q4 | 3.2 Million CHF | 167.41% |
| 2012 Q1 | 4.4 Million CHF | 358.67% |
| 2012 FY | - CHF | 55.51% |
| 2012 Q2 | -1.8 Million CHF | -141.02% |
| 2012 Q3 | -4.75 Million CHF | -163.16% |
| 2011 Q2 | -3.84 Million CHF | 5.42% |
| 2011 FY | - CHF | -394.9% |
| 2011 Q4 | -1.7 Million CHF | 64.71% |
| 2011 Q3 | -4.82 Million CHF | -25.49% |
| 2011 Q1 | -4.06 Million CHF | 15.64% |
| 2010 Q2 | 16.9 Million CHF | 818.66% |
| 2010 Q1 | -2.35 Million CHF | -725.53% |
| 2010 Q3 | -4.97 Million CHF | -129.4% |
| 2010 FY | - CHF | 126.73% |
| 2010 Q4 | -4.81 Million CHF | 3.14% |
| 2009 Q1 | -9.97 Million CHF | 0.0% |
| 2009 Q2 | -4.39 Million CHF | 55.99% |
| 2009 Q4 | 376 Thousand CHF | 109.77% |
| 2009 Q3 | -3.84 Million CHF | 12.37% |
| 2009 FY | - CHF | 4.93% |
| 2008 FY | - CHF | -133.39% |
| 2007 FY | - CHF | 75.02% |
| 2006 FY | - CHF | -20.31% |
| 2005 FY | - CHF | -22.96% |
| 2004 FY | - CHF | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|